398 related articles for article (PubMed ID: 24073977)
1. Therapeutic outcome and quality of life between urethral and detrusor botulinum toxin treatment for patients with spinal cord lesions and detrusor sphincter dyssynergia.
Kuo HC
Int J Clin Pract; 2013 Oct; 67(10):1044-9. PubMed ID: 24073977
[TBL] [Abstract][Full Text] [Related]
2. Satisfaction with urethral injection of botulinum toxin A for detrusor sphincter dyssynergia in patients with spinal cord lesion.
Kuo HC
Neurourol Urodyn; 2008; 27(8):793-6. PubMed ID: 18508331
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic satisfaction and dissatisfaction in patients with spinal cord lesions and detrusor sphincter dyssynergia who received detrusor botulinum toxin a injection.
Kuo HC
Urology; 2008 Nov; 72(5):1056-60. PubMed ID: 18533231
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic effects of detrusor botulinum toxin A injection on neurogenic detrusor overactivity in patients with different levels of spinal cord injury and types of detrusor sphincter dyssynergia.
Chen CY; Liao CH; Kuo HC
Spinal Cord; 2011 May; 49(5):659-64. PubMed ID: 21243000
[TBL] [Abstract][Full Text] [Related]
5. Real-World Data Regarding Satisfaction to Botulinum Toxin A Injection into the Urethral Sphincter and Further Bladder Management for Voiding Dysfunction among Patients with Spinal Cord Injury and Voiding Dysfunction.
Lee CL; Jhang JF; Jiang YH; Kuo HC
Toxins (Basel); 2022 Jan; 14(1):. PubMed ID: 35051007
[TBL] [Abstract][Full Text] [Related]
6. Concomitant Detrusor and External Urethral Sphincter Botulinum Toxin-A Injections in Male Spinal Cord Injury Patients with Detrusor Overactivity and Detrusor Sphincter Dyssynergia.
Huang YH; Chen SL
J Rehabil Med; 2022 Mar; 54():jrm00264. PubMed ID: 35174865
[TBL] [Abstract][Full Text] [Related]
7. Transperineal injection of botulinum toxin A for treatment of detrusor sphincter dyssynergia: localization with combined fluoroscopic and electromyographic guidance.
Tsai SJ; Ying TH; Huang YH; Cheng JW; Bih LI; Lew HL
Arch Phys Med Rehabil; 2009 May; 90(5):832-6. PubMed ID: 19406304
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic outcome and patient adherence to repeated onabotulinumtoxinA detrusor injections in chronic spinal cord-injured patients and neurogenic detrusor overactivity.
Chen SF; Kuo HC
J Formos Med Assoc; 2015 Jul; 114(7):583-9. PubMed ID: 24262922
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the impact on health-related quality of life of repeated detrusor injections of botulinum toxin in patients with idiopathic or neurogenic detrusor overactivity.
Gamé X; Khan S; Panicker JN; Kalsi V; Dalton C; Elneil S; Hamid R; Dasgupta P; Fowler CJ
BJU Int; 2011 Jun; 107(11):1786-92. PubMed ID: 21040367
[TBL] [Abstract][Full Text] [Related]
10. Effect of single botulinum toxin A injection to the external urethral sphincter for treating detrusor external sphincter dyssynergia in spinal cord injury.
Chen SL; Bih LI; Huang YH; Tsai SJ; Lin TB; Kao YL
J Rehabil Med; 2008 Oct; 40(9):744-8. PubMed ID: 18843427
[TBL] [Abstract][Full Text] [Related]
11. Long-term effects of repeated intradetrusor botulinum neurotoxin A injections on detrusor function in patients with neurogenic bladder dysfunction.
Pannek J; Göcking K; Bersch U
BJU Int; 2009 Nov; 104(9):1246-50. PubMed ID: 19426192
[TBL] [Abstract][Full Text] [Related]
12. The therapeutic effects of repeated detrusor injections between 200 or 300 units of onabotulinumtoxinA in chronic spinal cord injured patients.
Chen YC; Kuo HC
Neurourol Urodyn; 2014 Jan; 33(1):129-34. PubMed ID: 23494629
[TBL] [Abstract][Full Text] [Related]
13. Real-Life Treatment Outcome of Botulinum Toxin A Injection on Overactive Bladder and Voiding Dysfunction in Patients with Central Nervous System Lesions.
Jiang YH; Jhang JF; Chen SF; Kuo HC
Toxins (Basel); 2024 Mar; 16(3):. PubMed ID: 38535789
[TBL] [Abstract][Full Text] [Related]
14. Effectiveness of urethral injection of botulinum A toxin in the treatment of voiding dysfunction after radical hysterectomy.
Kuo HC
Urol Int; 2005; 75(3):247-51. PubMed ID: 16215314
[TBL] [Abstract][Full Text] [Related]
15. Effect of repeated detrusor onabotulinumtoxinA injections on bladder and renal function in patients with chronic spinal cord injuries.
Kuo HC; Liu SH
Neurourol Urodyn; 2011 Nov; 30(8):1541-5. PubMed ID: 21717505
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of onabotulinumtoxinA in patients with urinary incontinence due to neurogenic detrusor overactivity: a randomised, double-blind, placebo-controlled trial.
Cruz F; Herschorn S; Aliotta P; Brin M; Thompson C; Lam W; Daniell G; Heesakkers J; Haag-Molkenteller C
Eur Urol; 2011 Oct; 60(4):742-50. PubMed ID: 21798658
[TBL] [Abstract][Full Text] [Related]
17. Botulinum-A toxin for treating detrusor hyperreflexia in spinal cord injured patients: a new alternative to anticholinergic drugs? Preliminary results.
Schurch B; Stöhrer M; Kramer G; Schmid DM; Gaul G; Hauri D
J Urol; 2000 Sep; 164(3 Pt 1):692-7. PubMed ID: 10953127
[TBL] [Abstract][Full Text] [Related]
18. Surgical management of functional bladder outlet obstruction in adults with neurogenic bladder dysfunction.
Utomo E; Groen J; Blok BF
Cochrane Database Syst Rev; 2014 May; 2014(5):CD004927. PubMed ID: 24859260
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic Effects of Botulinum Toxin A, via Urethral Sphincter Injection on Voiding Dysfunction Due to Different Bladder and Urethral Sphincter Dysfunctions.
Lee YK; Kuo HC
Toxins (Basel); 2019 Aug; 11(9):. PubMed ID: 31450851
[TBL] [Abstract][Full Text] [Related]
20. Botulinum A toxin urethral injection for the treatment of lower urinary tract dysfunction.
Kuo HC
J Urol; 2003 Nov; 170(5):1908-12. PubMed ID: 14532805
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]